231 related articles for article (PubMed ID: 24848920)
1. Committee Opinion No. 601: Tamoxifen and uterine cancer.
Obstet Gynecol; 2014 Jun; 123(6):1394-1397. PubMed ID: 24848920
[TBL] [Abstract][Full Text] [Related]
2. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
Obstet Gynecol; 2006 Jun; 107(6):1475-8. PubMed ID: 16738185
[TBL] [Abstract][Full Text] [Related]
3. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
[TBL] [Abstract][Full Text] [Related]
4. Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment.
Neri F; Maggino T
Eur J Gynaecol Oncol; 2009; 30(4):357-60. PubMed ID: 19761121
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Lee M; Piao J; Jeon MJ
Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
[TBL] [Abstract][Full Text] [Related]
6. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
7. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
8. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
Behtash N; Hashemi R; Karimi Zarchi M
Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer and duration of tamoxifen.
Prescrire Int; 2015 Sep; 24(163):220. PubMed ID: 26417636
[TBL] [Abstract][Full Text] [Related]
10. Endometrial damage by antiestrogens in a postmenopausal breast cancer patient.
Ceci O; Bettocchi S; Marello F; Pellegrino A; Impedovo L; Di Venere R
Acta Obstet Gynecol Scand; 2002 Feb; 81(2):174-5. PubMed ID: 11942911
[No Abstract] [Full Text] [Related]
11. The role of tamoxifen in the treatment and prevention of breast cancer.
Jordan VC
Curr Probl Cancer; 1992; 16(3):129-76. PubMed ID: 1582240
[TBL] [Abstract][Full Text] [Related]
12. Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.
Gupta M; Kiruthiga KG
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123463
[TBL] [Abstract][Full Text] [Related]
13. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Chin J; Konje JC; Hickey M
Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
[TBL] [Abstract][Full Text] [Related]
14. Microwave endometrial ablation for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Zhu Y; Yang J
J Obstet Gynaecol Res; 2013 Sep; 39(9):1411-4. PubMed ID: 23815697
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen, screening and new oestrogen receptor modulators.
Neven P; Vergote I
Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):365-80. PubMed ID: 11476559
[TBL] [Abstract][Full Text] [Related]
16. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
Jordan VC; Gapstur S; Morrow M
J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
18. Effects of tamoxifen on the human female genital tract: review of the literature.
Varras M; Polyzos D; Akrivis Ch
Eur J Gynaecol Oncol; 2003; 24(3-4):258-68. PubMed ID: 12807236
[TBL] [Abstract][Full Text] [Related]
19. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.
Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M
J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834
[TBL] [Abstract][Full Text] [Related]
20. [The effects of tamoxifen on the female genital tract].
Mourits MJ; van der Zee AG; Willemse PH; Hollema H; de Vries EG
Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2315-20. PubMed ID: 14669536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
